Aperio Group’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | $1.71M | Sell |
30,251
-4,886
| -14% | -$276K | 0.01% | 1315 |
|
2020
Q3 | $1.67M | Buy |
35,137
+3,866
| +12% | +$183K | 0.01% | 1204 |
|
2020
Q2 | $1.84M | Buy |
31,271
+3,741
| +14% | +$221K | 0.01% | 1151 |
|
2020
Q1 | $1.3M | Buy |
27,530
+7,454
| +37% | +$352K | 0.01% | 1196 |
|
2019
Q4 | $1.21M | Sell |
20,076
-2,459
| -11% | -$149K | ﹤0.01% | 1330 |
|
2019
Q3 | $1.35M | Buy |
22,535
+612
| +3% | +$36.7K | 0.01% | 1236 |
|
2019
Q2 | $1.41M | Buy |
21,923
+3,279
| +18% | +$211K | 0.01% | 1226 |
|
2019
Q1 | $1.51M | Buy |
18,644
+2,864
| +18% | +$233K | 0.01% | 1166 |
|
2018
Q4 | $853K | Sell |
15,780
-424
| -3% | -$22.9K | ﹤0.01% | 1398 |
|
2018
Q3 | $836K | Buy |
16,204
+1,203
| +8% | +$62.1K | ﹤0.01% | 1509 |
|
2018
Q2 | $625K | Sell |
15,001
-2,976
| -17% | -$124K | ﹤0.01% | 1643 |
|
2018
Q1 | $792K | Buy |
17,977
+508
| +3% | +$22.4K | ﹤0.01% | 1454 |
|
2017
Q4 | $879K | Sell |
17,469
-528
| -3% | -$26.6K | ﹤0.01% | 1382 |
|
2017
Q3 | $912K | Buy |
17,997
+341
| +2% | +$17.3K | 0.01% | 1327 |
|
2017
Q2 | $898K | Buy |
17,656
+574
| +3% | +$29.2K | 0.01% | 1292 |
|
2017
Q1 | $687K | Sell |
17,082
-1,560
| -8% | -$62.7K | ﹤0.01% | 1364 |
|
2016
Q4 | $892K | Buy |
18,642
+6,876
| +58% | +$329K | 0.01% | 1188 |
|
2016
Q3 | $431K | Buy |
11,766
+1,479
| +14% | +$54.2K | ﹤0.01% | 1534 |
|
2016
Q2 | $240K | Buy |
10,287
+2,982
| +41% | +$69.6K | ﹤0.01% | 1765 |
|
2016
Q1 | $296K | Sell |
7,305
-9,516
| -57% | -$386K | ﹤0.01% | 1665 |
|
2015
Q4 | $1.04M | Buy |
16,821
+8,667
| +106% | +$537K | 0.01% | 996 |
|
2015
Q3 | $330K | Buy |
8,154
+3,789
| +87% | +$153K | ﹤0.01% | 1527 |
|
2015
Q2 | $251K | Buy |
4,365
+614
| +16% | +$35.3K | ﹤0.01% | 1738 |
|
2015
Q1 | $239K | Buy |
+3,751
| New | +$239K | ﹤0.01% | 1715 |
|